electroCore to Participate at LD Micro Main Event VXII

ECOR 10.10.2024

Full Press ReleaseSEC FilingsOur ECOR Tweets

About Gravity Analytica

Recent News

  • 01.07.2025 - electroCore Expands Intellectual Property Portfolio
  • 12.17.2024 - electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
  • 11.20.2024 - electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award

Recent Filings

  • 01.21.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.17.2025 - EX-99.1 EX-99.1
  • 01.17.2025 - 8-K Current report

ROCKAWAY, N.J., October 14, 2024 -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the LD Micro Main Event XVII on Tuesday, October 29 at 4:30 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Dan Goldberger, CEO will be representing the company and will be available for one-on-one meetings throughout the day on October 29.

DATE: Tuesday, October 29, 2024TIME: 4:30 p.m. PTWEBCAST:https://me24.sequireevents.com/

A live audio webcast and archive of the presentation will be available using the above dedicated link. Attendees interested in meeting with management should register for the conference or emailinvestors@electrocore.com.

About LD MicroLD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information of LD Micro, visitwww.ldmicro.com.

About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visitwww.electrocore.com.

Contact

ECOR Investor Relations(973) 302-9253investors@electrocore.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com